Please note that the information on this page (and other DrugSearch pages) is being updated
What is Methoxetamine?
Methoxetamine (also known as mexxy or MXE) is chemically similar to ketamine and other dissociative anaesthetics and has been marketed as a ketamine-substitute, although it appears that methoxetamine is much stronger than ketamine . Some sources suggest it was initially synthesised by an underground chemist for treatment of chronic pain.
People who take methoxetamine report feelings of mild euphoria, stimulation, hallucinogenic and dissociative effects. Users’ sense of time may shift and they may feel a loss of inhibitions. Negative effects include dizziness, double vision, impaired coordination, nausea, disorientation and confusion and unconsciousness. The long term effects of methoxetamine are unknown.
Methoxetamine has been present on the designer drug market since 2010. In April 2012, methoxetamine was given the first of a new kind of drug control, a Temporary Class Drug Order (TCDO), which banned sale of the drug but not possession, for up to 12 months while further classification was considered. In November 2012, methoxetamine was classified as a Class B drug.